← All themes

Genomics & Gene Editing

Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.

199 stocks

Gene Therapy

#	Name	Holding	Trade Value	% of Portfolio	Status
2126	HP Harbourvest Partners Boston, Massachusetts	$0	-$81K	–	Closed
2127	HP Harvey Partners Tarrytown, New York	$0	-$756K	–	Closed
2128	HVC Healthcare Value Capital Woodcliff Lake, New Jersey	$0	-$214K	–	Closed
2129	HS HighVista Strategies Boston, Massachusetts	$0	-$2.19M	–	Closed
2130	Horizon Investments Charlotte, North Carolina	$0	-$183K	–	Closed
2131	IGM Incline Global Management New York	$0	-$14.5M	–	Closed
2132	IC Intersect Capital San Ramon, California	$0	-$338K	–	Closed
2133	ICOA Investment Centers of America Bismarck, North Dakota	$0	-$226K	–	Closed
2134	JCP Jabre Capital Partners Geneva, Switzerland	$0	-$7.37M	–	Closed
2135	JDR Jay D. Rosenbaum	$0	-$353K	–	Closed
2136	JCI Jet Capital Investors New York	$0	-$18.9M	–	Closed
2137	JC Jetstream Capital Brentwood, Tennessee	$0	-$681K	–	Closed
2138	KAH Kathryn A. Hall	$0	-$674K	–	Closed
2139	K Kemper Chicago, Illinois	$0	-$1.41M	–	Closed
2140	KIM Kestrel Investment Management San Mateo, California	$0	-$21.7M	–	Closed
2141	LGC Laurel Grove Capital Los Angeles, California	$0	-$396K	–	Closed
2142	LCM LG Capital Management Owings Mills, Maryland	$0	-$880K	–	Closed
2143	LCP LGT Capital Partners Pfaeffikon, Switzerland	$0	-$7.39M	–	Closed
2144	LCG Lisanti Capital Growth New York	$0	-$3.41M	–	Closed
2145	LM Litespeed Management New York	$0	-$62.5M	–	Closed
2146	LOGI Long Oar Global Investors New York	$0	-$3.32K	–	Closed
2147	MC Maplelane Capital New York	$0	-$7.43M	–	Closed
2148	Meag Munich Ergo Munich, Germany	$0	-$14.9M	–	Closed
2149	MUSU Mitsubishi UFJ Securities (USA) New York	$0	-$2.72M	–	Closed
2150	Mizuho Securities USA New York	$0	-$7.31M	–	Closed